Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Neo-Adjuvant Atorvastatin in Postmenopausal Primary Breast Cancer
2008-005863-32Phase 2Completed
- Sponsor
- Department of Oncology
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin in breast cancer, sponsored by Department of Oncology. Primary endpoint: Change in tumor proliferation (Ki67) from baseline biopsy to post-treatment surgical specimen. Started Oct 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-005863-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005863-32.